Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life

Authors

Mariko Nagashima, Berlex Biosciences
Zheng-Feng Yin, Washington University School of Medicine in St. Louis
Lei Zhao, Berlex Biosciences
Kathy White, Berlex Biosciences
Yanhong Zhu, University of Michigan - Ann Arbor
Meredith Halks-Miller, Berlex Biosciences
George J. Broze Jr., Washington University School of Medicine in St. Louis
William P. Fay, University of Michigan - Ann Arbor
John Morser, Berlex Biosciences

Journal

The Journal of Clinical Investigation

Publication Date

2002

Volume

109

Issue

1

Inclusive Pages

101-110

Document Type

Open Access Publication

DOI

10.1172/JCI12119

Rights and Permissions

Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life Mariko Nagashima, Zheng-Feng Yin, Lei Zhao, Kathy White, Yanhong Zhu, Nina Lasky, Meredith Halks-Miller, George J. Broze Jr., William P. Fay, John Morser Published in Volume 109, Issue 1 J Clin Invest. 2002; 109(1):101–110 doi:10.1172/JCI12119

Recommended Citation

Nagashima, Mariko; Yin, Zheng-Feng; Zhao, Lei; White, Kathy; Zhu, Yanhong; Halks-Miller, Meredith; Broze, George J. Jr.; Fay, William P.; and Morser, John, "Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life." The Journal of Clinical Investigation. 109, 1. 101-110. (2002).
https://digitalcommons.wustl.edu/open_access_pubs/1425